News
BGLC
4.230
+2.42%
0.100
Weekly Report: what happened at BGLC last week (1208-1212)?
Weekly Report · 6d ago
12 Industrials Stocks Moving In Monday's After-Market Session
Benzinga · 12/08 21:05
Weekly Report: what happened at BGLC last week (1201-1205)?
Weekly Report · 12/08 09:01
12 Industrials Stocks Moving In Thursday's Pre-Market Session
Benzinga · 12/04 12:05
12 Industrials Stocks Moving In Wednesday's After-Market Session
Benzinga · 12/03 21:06
Bionexus Gene Lab completes investment in Fidelion Diagnostics
TipRanks · 12/03 13:50
BioNexus Gene Lab Corp. Acquires 15% Stake in Fidelion Diagnostics
Reuters · 12/03 13:45
BIONEXUS GENE LAB CORP. COMPLETES STRATEGIC INVESTMENT IN FIDELION DIAGNOSTICS; SECURES 15% EQUITY STAKE IN GLOBAL AI-ONCOLOGY PLATFORM AND EXCLUSIVE SOUTHEAST ASIAN RIGHTS FOR VITAGUARD™
Reuters · 12/03 13:45
BIONEXUS GENE LAB CORP - BUYS 15% EQUITY STAKE IN FIDELION DIAGNOSTICS
Reuters · 12/03 13:45
Bionexus Gene Lab secures $500M equity facility from ARC Group
TipRanks · 12/02 13:26
BIONEXUS GENE LAB CORP - ENTERS $500 MLN EQUITY PURCHASE AGREEMENT
Reuters · 12/02 13:05
BIONEXUS GENE LAB CORP - MAY ISSUE SHARES TO ARC GROUP INTERNATIONAL OVER 36 MONTHS
Reuters · 12/02 13:05
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization
Barchart · 12/02 07:05
Bionexus Gene Lab, Fidelion Diagnostics execute license for VitaGuard platform
TipRanks · 12/01 13:26
BioNexus Gene Lab Executes Intellectual Property License Agreement For Southeast Asia With Fidelion Diagnostics For VitaGuard Minimal Residual Disease Liquid Biopsy Platform
Benzinga · 12/01 13:07
BIONEXUS GENE LAB CORP - TO PAY $2 MLN LICENSE FEE TO FIDELION
Reuters · 12/01 13:04
BioNexus Gene Lab Secures Exclusive Southeast Asia License for VitaGuard MRD Platform
Reuters · 12/01 13:00
Weekly Report: what happened at BGLC last week (1124-1128)?
Weekly Report · 12/01 09:01
Weekly Report: what happened at BGLC last week (1117-1121)?
Weekly Report · 11/24 09:01
Weekly Report: what happened at BGLC last week (1110-1114)?
Weekly Report · 11/17 09:01
More
Webull provides a variety of real-time BGLC stock news. You can receive the latest news about Bionexus Gene La through multiple platforms. This information may help you make smarter investment decisions.
About BGLC
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.